Protagonist Therapeutics Reports Third Quarter Financial Results and Provides Corporate UpdatePRNewsWire • 11/04/20
Protagonist Therapeutics to Present Updated Clinical Data for Hepcidin Mimetic PTG-300 in Polycythemia Vera at the American Society for Hematology (ASH) 2020 Annual MeetingPRNewsWire • 11/04/20
Protagonist Therapeutics Announces Advancement of Oral IL-23 Receptor Antagonists Program in Collaboration with JanssenPRNewsWire • 10/29/20
Protagonist Therapeutics (PTGX) May Report Negative Earnings: Know the Trend Ahead of Q3 ReleaseZacks Investment Research • 10/28/20
Protagonist Therapeutics Receives Orphan Drug Designation from the European Medicines Agency for PTG-300 in Polycythemia VeraPRNewsWire • 10/21/20
Protagonist Therapeutics to Participate in the Jefferies Next Generation IBD Therapeutics Virtual Summit 2020PRNewsWire • 09/17/20
Protagonist Therapeutics to Participate in the H.C. Wainwright 22nd Annual Global Investment ConferencePRNewsWire • 09/10/20
Protagonist Therapeutics (PTGX) Reports Q2 Loss, Tops Revenue EstimatesZacks Investment Research • 08/06/20
Protagonist Therapeutics (PTGX) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 ReleaseZacks Investment Research • 07/29/20
Hepcidin Mimetic PTG-300 Receives U.S. FDA Orphan Drug Designation for the Treatment of Polycythemia VeraPRNewsWire • 06/18/20
Protagonist Therapeutics to Participate in the BMO Prescriptions for Success Healthcare ConferencePRNewsWire • 06/16/20
Protagonist Therapeutics: Robust Polycythemia Vera Data Is Just The BeginningSeeking Alpha • 06/10/20
Protagonist Therapeutics to Present at the 25th European Hematology Association (EHA) Annual CongressPRNewsWire • 06/04/20
Protagonist Therapeutics to Present at Two Upcoming Healthcare Investor ConferencesPRNewsWire • 05/28/20
Protagonist Therapeutics, Inc. (PTGX) CEO Dinesh Patel on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/13/20
Protagonist Therapeutics, Inc. (PTGX) CEO Dinesh Patel on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/11/20
Protagonist Therapeutics (PTGX) Reports Q4 Loss, Lags Revenue EstimatesZacks Investment Research • 03/10/20